Almirall

Almirall's reported carbon emissions

Almirall, a pharmaceutical preparation manufacturer headquartered in Spain, reported a total of approximately 147.6 million kg CO2e in emissions for the 2024 reporting year. This total comprises approximately 5.7 million kg CO2e from Scope 1 emissions (including stationary and mobile combustion, and fugitive emissions), and approximately 3.8 million kg CO2e from Scope 2 emissions (location-based). Scope 3 emissions were the largest contributor, amounting to approximately 141.9 million kg CO2e, with purchased goods and services being the most significant category. The company has established robust climate commitments, aiming for net-zero emissions by 2050. This long-term goal is supported by near-term targets aligned with a 1.5°C warming scenario. Specifically, Almirall is committed to an absolute reduction of 50% in Scope 1 and 2 greenhouse gas (GHG) emissions by 2030, using 2019 as the base year. Additionally, they aim for a 28% absolute reduction in Scope 3 GHG emissions by 2030, also from a 2019 baseline. Almirall is also committed to actively sourcing 100% renewable electricity annually through to 2030. Furthermore, Almirall has a long-term commitment to reduce absolute Scope 1, 2, and 3 GHG emissions by 90% by 2050 compared to 2019.